Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials

Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials

Protein kinase C (PKC), a family of phospholipid-dependent serine/threonine kinase, is classed into three subfamilies based on their structural and activation characteristics: conventional or classic PKC isozymes (cPKCs; α, βI, βII, and γ), novel or non-classic PKC isozymes (nPKCs; δ, ε, η, and θ),...

Full description

Bibliographic Details
Main Authors: Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata, Jeong-Hun Kang
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceutics
Subjects:
protein kinase C
cancer
inhibitor
activator
signaling pathway
clinical trial
Online Access:https://www.mdpi.com/1999-4923/13/11/1748

Similar Items

Similar Items